News Articles Tagged: KOR Agonist

Exploring Difelikefalin's Potential in Pain and Itch Management

An in-depth look at Difelikefalin, a selective kappa opioid receptor agonist, and its applications in pain and itch relief. NINGBO INNO PHARMCHEM CO.,LTD. discusses its therapeutic advantages.

Difelikefalin: A Breakthrough in Addressing Uremic Pruritus

Examine the role of Difelikefalin, a selective KOR agonist, in treating uremic pruritus. NINGBO INNO PHARMCHEM CO.,LTD. highlights its unique properties and patient benefits.

The Clinical Journey of Difelikefalin: From Lab to Patient

Discover the clinical significance of Difelikefalin, a peripherally restricted KOR agonist. NINGBO INNO PHARMCHEM CO.,LTD. discusses its development and impact on treating pruritus in hemodialysis patients.

Difelikefalin in Focus: Advancing Treatments for Chronic Itch

Explore the benefits and applications of Difelikefalin, a selective kappa opioid receptor agonist. NINGBO INNO PHARMCHEM CO.,LTD. discusses its role in pain management and treating conditions like CKD-aP.

The Science of Relief: How Difelikefalin Targets Itch

Delve into the pharmacological mechanism of Difelikefalin, a selective KOR agonist, and its application in managing pruritus. Explore its benefits for patients with chronic kidney disease.